{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:36:10Z","timestamp":1759336570069,"version":"3.40.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"\u201cRed de Investigaci\u00f3n Cardiovascular del Instituto de Salud Carlos III, RIC\u201d, \u201cProyecto de Excelencia","award":["P08-CTS-03530"],"award-info":[{"award-number":["P08-CTS-03530"]}]},{"name":"Consejer\u00eda de Innovaci\u00f3n y Ciencia de la Junta de Andaluc\u00eda\u201d and European Union"},{"name":"Botin Foundation and the Spanish Ministry of Science and Innovation (SAF and CIBERNED programs)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ejphar.2014.02.046","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T16:32:57Z","timestamp":1395937977000},"page":"130-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Low-dose combination of Rho kinase and L-type Ca2+ channel antagonists for selective inhibition of depolarization-induced sustained arterial contraction"],"prefix":"10.1016","volume":"732","author":[{"given":"Cristina","family":"Porras-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Gonz\u00e1lez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Calder\u00f3n-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"L\u00f3pez-Barneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ure\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.02.046_bib1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"Abernethy","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2014.02.046_bib2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/hh1201.092094","article-title":"Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells","volume":"88","author":"Akao","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2014.02.046_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cvr\/cvp006","article-title":"Hypoxia inhibits vasoconstriction induced by metabotropic Ca2+ channel-induced Ca2+ release in mammalian coronary arteries","volume":"82","author":"Calder\u00f3n-S\u00e1nchez","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2014.02.046_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/00005344-199705000-00019","article-title":"Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil","volume":"29","author":"Cremers","year":"1997","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.02.046_bib5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCRESAHA.109.213967","article-title":"Genetic ablation of L-type Ca2+ channels abolishes depolarization-induced Ca2+ release in arterial smooth muscle","volume":"106","author":"Fern\u00e1ndez-Tenorio","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2014.02.046_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/CIRCRESAHA.111.240127","article-title":"Metabotropic regulation of RhoA\/Rho-associated kinase by L-type Ca2+ channels: new mechanism for depolarization-evoked mammalian arterial contraction","volume":"108","author":"Fern\u00e1ndez-Tenorio","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2014.02.046_bib7","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","article-title":"Nifedipine: dose-related increase in mortality in patients with coronary heart disease","volume":"92","author":"Furberg","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2014.02.046_bib8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/01.RES.78.1.148","article-title":"Electrical activity underlying rhythmic contraction in human pial arteries","volume":"78","author":"Gokina","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2014.02.046_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0002-9343(93)90314-F","article-title":"Verapamil intoxication: a literature review of overdoses and discussion of therapeutic options","volume":"95","author":"Hofer","year":"1993","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2014.02.046_bib10","first-page":"145","article-title":"Impact of subarachnoid hemorrhage on local and global calcium signaling in cerebral artery myocytes","volume":"110","author":"Koide","year":"2011","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1016\/j.ejphar.2014.02.046_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/01.RES.0000201960.04223.3c","article-title":"Rho kinases in cardiovascular physiology and pathophysiology","volume":"98","author":"Loirand","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2014.02.046_bib12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/hc1002.105938","article-title":"Suppression of coronary artery spasm by the rho-kinase inhibitor fasudil in patients with vasospastic angina","volume":"105","author":"Masumoto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2014.02.046_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/bj20020191","article-title":"Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase","volume":"364","author":"Mita","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2014.02.046_bib14","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1161\/01.RES.0000131495.93500.3c","article-title":"High blood pressure upregulates arterial L-type Ca2+ channels: is membrane depolarization the signal?","volume":"94","author":"Pesic","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2014.02.046_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2125.1988.tb05256.x","article-title":"The pharmacokinetics of oral nifedipine\u2014a population study","volume":"25","author":"Renwick","year":"1988","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.02.046_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/01.RES.0000090998.08629.60","article-title":"Ca2+-dependent activation of Rho and Rho-kinase in membrane depolarization induced and receptor stimulation-induced vascular smooth muscle contraction","volume":"93","author":"Sakurada","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2014.02.046_bib17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00005344-199006000-00006","article-title":"Negative inotropic properties of isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardial tissue","volume":"15","author":"Schwinger","year":"1990","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.02.046_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2005.06.003","article-title":"Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial","volume":"238","author":"Shibuya","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2014.02.046_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0022-3565(25)10629-0","article-title":"Calcium channel antagonists: cardiovascular selectivity of action","volume":"274","author":"Sun","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.02.046_bib20","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2005.07.047","article-title":"Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial","volume":"46","author":"Vicari","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2014.02.046_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2176\/nmc.51.679","article-title":"Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine","volume":"51","author":"Zhao","year":"2011","journal-title":"Neurol. Med. Chir."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991400226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T05:28:25Z","timestamp":1746163705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991400226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":21,"alternative-id":["S001429991400226X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.02.046","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose combination of Rho kinase and L-type Ca2+ channel antagonists for selective inhibition of depolarization-induced sustained arterial contraction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.02.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}